DAREON™-9: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With Small Cell Lung Cancer When Taken Together With a Single Agent Chemotherapy
Clinical trial NCT05990738 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05990738
- Sponsor
- Boehringer Ingelheim
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-14
- Primary completion
- 2027-03-30
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.